![Motor neuron disease, TDP-43 pathology, and memory deficits in mice expressing ALS–FTD-linked UBQLN2 mutations | PNAS Motor neuron disease, TDP-43 pathology, and memory deficits in mice expressing ALS–FTD-linked UBQLN2 mutations | PNAS](https://www.pnas.org/cms/10.1073/pnas.1608432113/asset/17de35c0-676e-4cc4-b7d4-bb68cc81f735/assets/graphic/pnas.1608432113fig01.jpeg)
Motor neuron disease, TDP-43 pathology, and memory deficits in mice expressing ALS–FTD-linked UBQLN2 mutations | PNAS
![Humanising mice to enable modelling of neurodegenerative diseases | UCL Queen Square Institute of Neurology - UCL – University College London Humanising mice to enable modelling of neurodegenerative diseases | UCL Queen Square Institute of Neurology - UCL – University College London](https://www.ucl.ac.uk/ion/sites/ion/files/styles/large_image/public/graph_abstract_revised1.jpg?itok=cWnBiFcY)
Humanising mice to enable modelling of neurodegenerative diseases | UCL Queen Square Institute of Neurology - UCL – University College London
![Figure 3.1 from The neuromuscular transmission of the SOD 1 ( G 93 A ) mouse model of Amyotrophic Lateral Sclerosis | Semantic Scholar Figure 3.1 from The neuromuscular transmission of the SOD 1 ( G 93 A ) mouse model of Amyotrophic Lateral Sclerosis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/3c9acec98cb1a0a0060bc2ed4086c6191c3fdf28/32-Figure3.1-1.png)
Figure 3.1 from The neuromuscular transmission of the SOD 1 ( G 93 A ) mouse model of Amyotrophic Lateral Sclerosis | Semantic Scholar
![AAV9-mediated gene delivery of MCT1 to oligodendrocytes does not provide a therapeutic benefit in a mouse model of ALS: Molecular Therapy - Methods & Clinical Development AAV9-mediated gene delivery of MCT1 to oligodendrocytes does not provide a therapeutic benefit in a mouse model of ALS: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/attachment/3b365057-92c6-4519-a160-716214c5694a/fx1_lrg.jpg)
AAV9-mediated gene delivery of MCT1 to oligodendrocytes does not provide a therapeutic benefit in a mouse model of ALS: Molecular Therapy - Methods & Clinical Development
![MicroRNA-206 Delays ALS Progression and Promotes Regeneration of Neuromuscular Synapses in Mice | Science MicroRNA-206 Delays ALS Progression and Promotes Regeneration of Neuromuscular Synapses in Mice | Science](https://www.science.org/cms/10.1126/science.1181046/asset/ed7b4565-8ab1-4c16-ab4f-93a37e5bcc7c/assets/graphic/326_1549_f2.jpeg)
MicroRNA-206 Delays ALS Progression and Promotes Regeneration of Neuromuscular Synapses in Mice | Science
![November 2015 Pathomechanistic model mice of sporadic ALS: Conditional ADAR2 knockout mice AR2 | Experimental Animal Division (RIKEN BRC) November 2015 Pathomechanistic model mice of sporadic ALS: Conditional ADAR2 knockout mice AR2 | Experimental Animal Division (RIKEN BRC)](https://mus.brc.riken.jp/en/wp-content/uploads/2015/11/201511.png)
November 2015 Pathomechanistic model mice of sporadic ALS: Conditional ADAR2 knockout mice AR2 | Experimental Animal Division (RIKEN BRC)
![Frontiers | Mouse Models of C9orf72 Hexanucleotide Repeat Expansion in Amyotrophic Lateral Sclerosis/ Frontotemporal Dementia Frontiers | Mouse Models of C9orf72 Hexanucleotide Repeat Expansion in Amyotrophic Lateral Sclerosis/ Frontotemporal Dementia](https://www.frontiersin.org/files/Articles/273825/fncel-11-00196-HTML/image_m/fncel-11-00196-g001.jpg)
Frontiers | Mouse Models of C9orf72 Hexanucleotide Repeat Expansion in Amyotrophic Lateral Sclerosis/ Frontotemporal Dementia
![TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration | PNAS TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration | PNAS](https://www.pnas.org/cms/10.1073/pnas.0912417107/asset/2e535a42-bccf-434f-a669-2405b4a5abaa/assets/graphic/pnas.0912417107fig01.jpeg)
TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration | PNAS
![Drug target validation in mouse models of ALS. (A) Comparison between... | Download Scientific Diagram Drug target validation in mouse models of ALS. (A) Comparison between... | Download Scientific Diagram](https://www.researchgate.net/publication/233830839/figure/fig8/AS:202753721802772@1425351662774/Drug-target-validation-in-mouse-models-of-ALS-A-Comparison-between-whole-genome.png)
Drug target validation in mouse models of ALS. (A) Comparison between... | Download Scientific Diagram
![Molecules | Free Full-Text | A Novel Anti-Inflammatory d-Peptide Inhibits Disease Phenotype Progression in an ALS Mouse Model Molecules | Free Full-Text | A Novel Anti-Inflammatory d-Peptide Inhibits Disease Phenotype Progression in an ALS Mouse Model](https://pub.mdpi-res.com/molecules/molecules-26-01590/article_deploy/html/images/molecules-26-01590-ag.png?1615861404)
Molecules | Free Full-Text | A Novel Anti-Inflammatory d-Peptide Inhibits Disease Phenotype Progression in an ALS Mouse Model
![Neuroprotective effects of siRNAp11 in the SOD1-G93A mouse model of... | Download Scientific Diagram Neuroprotective effects of siRNAp11 in the SOD1-G93A mouse model of... | Download Scientific Diagram](https://www.researchgate.net/publication/335321624/figure/fig4/AS:958965122863115@1605646510407/Neuroprotective-effects-of-siRNAp11-in-the-SOD1-G93A-mouse-model-of-ALS-a-In-situ.png)
Neuroprotective effects of siRNAp11 in the SOD1-G93A mouse model of... | Download Scientific Diagram
![Tempol improves neuroinflammation and delays motor dysfunction in a mouse model (SOD1G93A) of ALS | Journal of Neuroinflammation | Full Text Tempol improves neuroinflammation and delays motor dysfunction in a mouse model (SOD1G93A) of ALS | Journal of Neuroinflammation | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12974-019-1598-x/MediaObjects/12974_2019_1598_Fig1_HTML.png)
Tempol improves neuroinflammation and delays motor dysfunction in a mouse model (SOD1G93A) of ALS | Journal of Neuroinflammation | Full Text
![A New AAV10-U7-Mediated Gene Therapy Prolongs Survival and Restores Function in an ALS Mouse Model - ScienceDirect A New AAV10-U7-Mediated Gene Therapy Prolongs Survival and Restores Function in an ALS Mouse Model - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1525001617302514-fx1.jpg)
A New AAV10-U7-Mediated Gene Therapy Prolongs Survival and Restores Function in an ALS Mouse Model - ScienceDirect
![IJMS | Free Full-Text | Novel P2X7 Antagonist Ameliorates the Early Phase of ALS Disease and Decreases Inflammation and Autophagy in SOD1-G93A Mouse Model IJMS | Free Full-Text | Novel P2X7 Antagonist Ameliorates the Early Phase of ALS Disease and Decreases Inflammation and Autophagy in SOD1-G93A Mouse Model](https://pub.mdpi-res.com/ijms/ijms-22-10649/article_deploy/html/images/ijms-22-10649-ag.png?1634438729)